Cell adhesion as a novel approach to determining the cellular binding motif on the severe acute respiratory syndrome coronavirus spike protein

J Virol Methods. 2014 Jun:201:1-6. doi: 10.1016/j.jviromet.2014.01.022. Epub 2014 Feb 13.

Abstract

Emerging life threatening pathogens such as severe acute aspiratory syndrome-coronavirus (SARS-CoV), avian-origin influenzas H7N9, and the Middle East respiratory syndrome coronavirus (MERS-CoV) have caused a high case-fatality rate and psychological effects on society and the economy. Therefore, a simple, rapid, and safe method to investigate a therapeutic approach against these pathogens is required. In this study, a simple, quick, and safe cell adhesion inhibition assay was developed to determine the potential cellular binding site on the SARS-CoV spike protein. Various synthetic peptides covering the potential binding site helped to minimize further the binding motif to 10-25 residues. Following analyses, 2 peptides spanning the 436-445 and 437-461 amino acids of the spike protein were identified as peptide inhibitor or peptide vaccine candidates against SARS-CoV.

Keywords: Binding motif; SARS-CoV; Spike protein; Vero E6 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / isolation & purification
  • Binding Sites
  • Cell Adhesion*
  • Cell Line
  • Humans
  • Peptides / isolation & purification
  • Protein Binding
  • Severe acute respiratory syndrome-related coronavirus / physiology*
  • Spike Glycoprotein, Coronavirus / metabolism*
  • Virus Attachment*

Substances

  • Antiviral Agents
  • Peptides
  • Spike Glycoprotein, Coronavirus